HIV-2 diagnosis and quantification in high-risk patients

18Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Current diagnostic assays for HIV-1 do not always test for the presence of HIV-2 in the United States. We present the case of a patient from Cape Verde, who was admitted to our hospital with rapidly deteriorating neurological function and multiple white matter lesions on MRI likely secondary to progressive multifocal leukoencephalopathy (PML). Initially, the patient had a positive EIA for HIV, but a negative HIV-1 Western Blot and no viral load detected on a branched-DNA assay. A repeat viral load by reverse transcriptase methodology (RT-DNA) detected 121,000 copies and an HIV-2 Western Blot was positive. The case highlights an extremely rare presentation of HIV-2 with severe neurological disease. We discuss the different tests available for the diagnosis and monitoring of HIV-2 in the United States. © 2008 Chan et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Chan, P. A., Wakeman, S. E., Flanigan, T., Cu-Uvin, S., Kojic, E., & Kantor, R. (2008). HIV-2 diagnosis and quantification in high-risk patients. AIDS Research and Therapy, 5. https://doi.org/10.1186/1742-6405-5-18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free